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The renin-angiotensin system (RAS) plays a crucial role in the regulation of renal, 
cardiac, and vascular physiology. This system regulates in vivo blood pressure and fluid 
balance. As renal blood flow decreases, the kidneys convert prorenin into renin and 
secrete it into the circulatory system. Renin then converts angiotensinogen into 
angiotensin I (ang-I). The ang-I is then converted into angiotensin II (ang-II) by the 
angiotensin-converting enzyme (ACE). Ang-II, a vasoconstrictor, increases blood 
pressure by causing the blood vessels to narrow. Recent evidence suggests that RAS 
may be involved in the progression of valve disease, most notably, aortic stenosis.  
The first part of this Honors thesis study was focused on the ACE and chymase 
inhibitors, quinaprilant and chymostatin, respectively. The aims of this study were to 
determine if ang-I is being converted into ang-II locally within the valve milieu. Results 
showed that the mechanical characteristics of the tissue were altered when the 
angiotensin converting enzymes were inhibited while the sample was exposed to ang-I. 
This suggests that ang-I is being converted into ang-II within the valve tissue. The binding 
of ang-I and ang-II to the receptors was investigated by inhibiting their respective receptor 
subtypes. The samples were treated with either ang-II type 1 receptor (AT-1R) inhibitor, 
losartan, or ang-II type 2 receptor (AT-2R) inhibitor, PD123-319, in combination with ang-
I or ang-II. Blocking AT-1R mitigates the effect from ang-II binding while blocking AT-2R 
allows ang-II to only bind to AT-1R which increases its vasoconstrictive effect. Biaxial 
tensile testing was used to quantify the mechanical characteristics of the tissue; the 




The second half of the study was focused on formulating a constitutive model to fit 
the data and determining the strain energy of the samples. The constitutive model chosen 
was the Choi-Vito model since it is commonly used in modeling the non-linear mechanics 
of anisotropic soft tissue. To test the reliability of the mathematical model, the strain 




Chapter 1: Introduction  
1.1 Heart Anatomy and Physiology 
The heart is the center of the circulatory system. The circulatory system is divided 
into two parts which both start and end at the heart. The heart is divided longitudinally to 
accommodate the separate circulations. The pulmonary circulation is comprised of blood 
pumped from the right side of the heart through the lungs, which oxygenates the blood, 
and to the left atrium of the heart. At this point the blood has entered the systemic 
circulation. The blood enters the left ventricle and is pumped out through the aorta to all 
of the organs and tissues – with the exception of the lungs – and then to the right atrium. 
The ventricles are separated by a wall, the interventricular septum, to keep the pulmonary 
and systemic circulations separated [1]. 
 
In each half of the heart there are two chambers, an atrium and a ventricle, and 
two one-way valves. Situated between the atrium and the ventricle is an atrioventricular 
Figure 1. Diagram of circulation through 
the heart [2]. 
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valve; this valve is designed to only allow blood to flow from the atrium to the ventricles 
[1]. The second valve, also known as the ventriculoarterial (VA) valve, is located between 
the ventricle and one of the arteries – either the pulmonary artery or the aorta depending 
on which side of the heart it is in. The pulmonary and aortic valves are also referred to as 
semilunar valves due to their half-moon cusp shapes. These valves keep blood flowing 
through and away from the heart and ensure no backflow – assuming no pathophysiology.  
1.2 Cardiovascular Disease 
There are many forms of cardiovascular disease which can affect the physiology 
of the heart and blood vessels. Chief among these diseases is atherosclerosis, a 
condition in which plaque builds up in the arteries and restricts blood flow. If flow is 
obstructed this will lead to an ischemic event in which tissue dies due to lack of oxygen. 
If this ischemic event occurs due to a coronary artery being blocked it is called a heart 
attack or myocardial infarction [3].  
Cardiovascular disease is not limited to blockage of the vessels, it can affect 
multiple areas of the cardiovascular system including the heart valves. Diseases affecting 
the heart valves fall into two distinct categories: regurgitation and stenosis. Gaps between 
the valve leaflets allow backflow to occur which is labeled as regurgitation. Conversely, 
stenosis is a disease in which the valve leaflets have stiffened and do not open fully. This 
stiffening is usually due to the valve thickening by calcification. This thickening, in turn, 
increases the pressure that the heart must exert and the valves experience which alters 
the fiber composition within the valves.  
Typically, regurgitation and stenosis afflict the left side of the heart more than the 
right side due to the higher pressures. While up to 1.5 million Americans suffer from aortic 
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stenosis, an approximate 500,000 people suffer from severe aortic stenosis. Of those 
suffering from severe aortic stenosis, 50% will not survive more than two years after the 
onset of symptoms [4-7]. Currently, the only treatment option is through direct intervention 
which can either be a transcatheter or a surgical procedure. Current research is working 
to identify a viable treatment option and it is thought that the renin-angiotensin system 
could be involved.  
1.3 The Renin-Angiotensin System (RAS) 
The renin-angiotensin system (RAS) plays a role in the regulation of blood 
pressure and is a regulatory system of renal and cardiovascular function [8-10]. Activation 
of the RAS occurs when angiotensinogen is cleaved by renin, a proteinase enzyme 
released by the kidneys, to form angiotensin I [8-17] (ang-I). Ang-I is then converted to 
angiotensin II [1-8] (ang-II) by angiotensin-converting enzyme (ACE). Ang-II then binds 
to two different receptor subtypes, type 1 ang-II receptor (AT-1R) or type 2 ang-II receptor 




AT-1R is present in the kidney, heart, brain, adrenal cortex and vessel walls. It 
mediates the effects of ang-II in most cardiovascular functions. AT-2R is mostly 
AT-1R AT-2R
ACE
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Figure 2. The renin-angiotensin system (RAS). Figure 




expressed in the brain and adrenal medulla. Little is known about the role of AT-2R in 
cardiovascular function, however it is expressed in the vascular wall and cardiac 
ventricles [12, 13]. AT-1R causes vasoconstriction, cell-proliferation, endothelial 
dysfunction, and hypertrophy whereas AT-2R causes vasodilation, anti-proliferation, and 
apoptosis which counterbalances the effects of AT-1R [14-16]. There are also non-
angiotensin converting enzymes such as chymase and cathepsins which also play a role 
in the conversion of ang-I to ang-II. The ability for chymase to generate ang-II in the heart 
tissue is not well known, however it is present in diseased tissue [17]. RAS regulates 
intravascular volume, blood pressure, and tissue repair, and though it can be protective, 
when highly stimulated it can cause vasoconstriction, vascular smooth muscle 
proliferation, endothelial dysfunction, inflammation, fibrosis, and thrombosis [12, 18].  
There has been research conducted on the influence of ang-II on the 
biomechanical properties of aortic valves. Biaxial testing showed that ang-II increased the 
stiffness of aortic valve leaflets, and it is believed that the increase in collagen content 
altered the mechanical properties [19].  Studies have also shown that stenotic aortic 
valves have an increase in expression of ACE and AT-1R in comparison to healthy valves. 
This suggests that RAS may participate in the progression of aortic stenosis and blocking 
RAS can potentially serve as a therapeutic strategy against valve stenotic disease [20].  
1.4 Tissue Mechanics 
1.4.1 Mechanical Testing 
 To obtain a full understanding of the mechanics of tissues biaxial tensile testing 
must be used; single-axial tensile testing is not sufficient. Uniaxial testing does not 
capture the cross-coupling effect of the axes. This cross-coupling effect is due to the fact 
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that most tissues in the human body are anisotropic; anisotropic tissues possess different 
mechanical properties along different axes. For example, skeletal muscle fibers are 
aligned along the axis of contraction which increases their strength and contractile force 
in that direction. However, in the direction perpendicular to the axis of contraction the 
muscle is much weaker.  
1.4.2 Constitutive Modeling 
Phenomenological constitutive models can be used to quantify the material 
properties of soft tissue such as the aortic valve leaflets [21]. The models can account for 
regional variation and properties of the leaflet layers; the stress environment the cells 
undergo can also be predicted with a model [22]. Some of the most widely used models 
for biological tissue are the Fung, Mooney-Rivlin, and Choi-Vito models. For this research 
project the Choi-Vito model was chosen since each term in the strain energy formula, 
Equation (6), contains its own exponential as compared to the Fung model which only 
utilizes one exponential for every term, Equation (5). By possessing the individual terms, 
it was thought that the Choi-Vito model would provide a better fit for the anisotropic tissue. 
Additionally, the Choi-Vito model was originally developed to model the mechanics of the 
pericardium, another type of cardiac tissue [23]. The material constants derived from the 
model are important for developing future computational simulations of the tissue 
mechanics and deformation. Simulations can also be performed using specimen-specific 
constants, however, material constants representing a generic (average) tissue response 




Understanding the RAS pathway in hypertension has led to various therapeutic 
treatments by blocking ACE or AT-1R. However, the effects that RAS have on the valve 
are still not well known. The objective of this study is to investigate how RAS affects the 
mechanical properties of the aortic valve. We hypothesize that the conversion of ang-I to 
ang-II through ACE or chymase happens locally in the valve increasing the amount of 
ang-II to bind to the cell. We hypothesize that the binding of ang-II to AT-1R receptor 
causes the mechanical properties to exhibit diseased functions such as increased 
stiffness and collagen alignment. To do so, we inhibited AT-1R to see if, by not binding, 
the effects would be mitigated. We inhibited AT-2R to test if more ang-II binds to AT-1R 
and in turn induces disease-like states. The areal strain and anisotropy was calculated 
with the results from the equibiaxial tests (1:1 ratio). The second objective was to fit a 
constitutive model to the experimental data stretched at various tension ratios, as using 
only equibiaxial data is limiting. In addition, we can calculate the difference in energy 
strain being seen. I used the Choi-Vito model as it is a model commonly used in 




Chapter 2: Materials and Methods 
2.1 Tissue Treatment 
Porcine hearts were obtained from Cockrum’s Custom Meat Processing and 
Taxidermy (Rudy, AR) or Braunschweig Processing (Neosho, MO), both of which are 
FDA-approved abattoirs. The hearts were transported back to the University of Arkansas 
in cold, sterile dPBS. To view the full preparation protocol please refer to Appendix A1. 
The three aortic valve leaflets were then extracted from the porcine hearts using aseptic 
techniques. The valves were pooled and washed in dPBS. Next, they were incubated with 
150 U/mL penicillin/streptomycin in PBS for 10 minutes. The leaflets were cultured in 
DMEM supplemented with 2% FBS, 150 U/mL P/S, and HEPES.  
The local conversion of ang-I to ang-II was investigated by inhibiting the angiotensin 
converting enzyme and chymase. Once extracted, samples were either treated with ACE 
inhibitor quinaprilant (1 μM) or chymase inhibitor chymostatin (10 μM) and ang-I. The 
binding of ang-I and ang-II to the receptors was investigated by inhibiting AT-1R or AT-
2R. The samples were treated with either AT-1R inhibitor losartan (1μM) or AT-2R 
inhibitor PD123-319 (1μM) for 1 day before being treated in combination with ang-I (10 
μM) or ang-II (10 μM) for an additional 48 hrs. Tissue was immediately tested at the end 
of the treatment period as per the protocol in Appendix A2 [24]. 
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2.2 Biaxial Mechanical Testing 
The mechanics of the whole valve tissue was determined through biaxial tensile 
testing. Samples were cut into 1cm2 specimens. The specimens could not be directly 
attached to the arms of the tensile tester and thus they needed to be attached to a frame. 
Cardboard was laser cut into a 6x6 cm square with a smaller square cut into the middle 
of it, see Figure (3A). The specimen was centered in the frame and three staples were 
used on each side to affix the specimen to the frame. The corners of the frame were cut 
such that each side could be pulled independently as seen in Figure 3B. 
Shear stress was considered to be negligible since the samples were oriented 
such that the radial direction was aligned with the y-axis and the circumferential direction 
was aligned with the x-axis. In Figure 4 the alignment of the can be more clearly 
visualized.  
A B 
Figure 3. A) Depiction of the cardboard frame which 
was laser cut. B) Sample attached to the frame and 




A four-marker array, in the form of beads, was then affixed onto the tissue; the 
beads’ displacements were tracked. The sample was then mounted onto a 
TestResources biaxial testing device Figure 5. The sample was immersed into a saline 
bath at 37C to prevent the tissue from drying out, and to maintain physiological 
temperature and osmolarity.   
 
Figure 4. Aortic valve leaflet with the 




Figure 5: TestResources biaxial testing device. Figure obtained from Jessica 
Perez.  
 
The sample was brought to a tare load of 0.05N along each axis and then 
preconditioned by cycling 20 times at 90 N/m. Mechanical testing in the circumferential 
and radial axes consisted of the five following tension ratios with a maximum tension of 
90 N/m:  Tcirc:Trad – 1:1, 1:0.75, 1:0.5, 0.75:1, 0.5:1. A full table of the ratios and the 
tensions can be seen in Table 1. The 1:1 tension data was the only ratio used to quantify 
the biomechanical effects of the RAS mediators; the full data set was used for constitutive 
modeling. To view the complete biaxial protocol please refer to the ‘Biaxial Stretching of 




Table 1. The biaxial stretching ratios and the corresponding tensions (N/m).  







Position-based settings were used to operate the system at a data acquisition rate 
of 100 Hz. The forces along the axes were measured via force transducers within the 
biaxial tensile tester and the displacement of the sample was measured by a CCD camera 
which detected the four marker array and captured images at a rate of 100 Hz.  
2.3 Mechanical Characterization  
The deformation gradient, F, and Green strain, E, was calculated for each sample 
with a custom Matlab code. The deformation gradient is the partial derivative of each 
deformed x vector with respect to the corresponding undeformed or reference vector, X. 
The formula for the deformation gradient can be seen below in equation (1). The Green’s 




   (1)           
𝐸 = 0.5(𝐹𝑇𝐹 − 𝐼)  (2) 
The 1st and 2nd Piola-Kirchhoff (P-K) stress. The 1st and 2nd P-K stresses, P and S 








−1𝑃 =  
𝜕𝑊
𝜕𝐸𝑖𝑗
  (4) 
 The thickness was measured by placing a portion of the sample into OCT, 
sectioning samples, and then using ImageJ to measure the thickness. The width of the 
sample is 1cm since the specimen was cut to 1cm x 1cm. Areal strain is calculated by 
multiplying Exx and Eyy together. The anisotropic index is calculated by dividing the 
max Exx and Eyy. These values will be displayed in the command window. Finally, an 
excel file will be generated (plotdata.xlsx) which contains E, S, and P in the 
circumferential and radial directions and the areal strain.  
2.4 Constitutive Modeling 
In this study the Choi-Vito model [23] was used to fit the experimental data. This 
model was chosen because it is similar to the Fung model [26], however, it separates the 
different directions into individual exponentials. The Fung and Choi-Vito strain energy 




(exp(𝑄) − 1) (5) 
𝑊 = 𝑐(𝑒𝑄1 + 𝑒𝑄2 + 𝑒𝑄3 − 3) (6) 
Where in the Fung model, 𝑄 = 𝑐1𝐸11
2 + 𝑐2𝐸22
2 + 2𝑐3𝐸11𝐸22 and in the Choi-Vito 
model:  
 𝑄1 = 𝑐1𝐸𝑥𝑥
2  
 𝑄2 = 𝑐2𝐸𝑦𝑦
2  
𝑄3 = 2𝑐3𝐸𝑥𝑥𝐸𝑦𝑦 
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Additionally, c and ci are material parameters, and Exx and Eyy are the Green strain 
values in the circumferential and radial directions, respectively. The in-plane 2nd Piola-
Kirchhoff stresses for the Choi-Vito model now become [27]:  
𝑆11 = 𝑐[𝑐1𝐸11 exp(𝑐1𝐸11
2 ) + 𝑐3𝐸22 exp(𝑐3𝐸11𝐸22)] (7) 
𝑆22 = 𝑐[𝑐2𝐸22 exp(𝑐2𝐸22
2 ) + 𝑐3𝐸11 exp(𝑐3𝐸11𝐸22)] (8) 
 The constants for the Choi-Vito model were calculated using a custom Matlab 
code. The code uses the objective function to calculate the sum of squares of the 
residuals using equations (7) and (8). The minimization of the objective function was 
done by using the function fmincon which was bound by the following constraints [28]: 
c > 0 
c1 > |c3| 
c2 > |c3| 
 
The optimal values for the constants and the total R2 are calculated. Using the 
material constants, a non-linear anisotropy index (AI) is computed. The AI can be 
calculated from the material constants through various equations. Kural et al calculated 
the AI by utilizing equation (9) while originally Choi and Vito proposed calculating AI 
through equation (10) [23, 29]. While both equations are useful neither of them produce 
intuitive values. The equation used for this study employed a modified version of the Kural 
equation as seen in equation (11). This modified version is much more intuitive as a value 
of 1 corresponds to a completely isotropic tissue and a value approaching to 0 
corresponds to a completely anisotropic tissue.   
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𝐴𝐼 =  
𝑐1
𝑐2
  (9)      𝐴𝐼 = √
𝑐1
𝑐2
  (10)    𝐴𝐼 =
𝑐2
𝑐1
  (11) 
Using the constants, another custom Matlab code plots two figures using the model 
fit. The first figure generated shows plots of the individual ratios (five subplots) with the 
circumferential and radial directions on one graph. The second figure generated displays 
plots all of the ratios in either the circumferential or radial direction (2 subplots). 
Additionally, strain energy contour plots are generated. Contour plots are used to show 
that the material constants fulfill the positive definiteness requirement of elasticity tensor 
by satisfying the strain energy convexity constraints [30]. Contour plots are generated by 
graphing E11 and E22 in a range from -1.5 to 1.5 into the strain energy Eq. Error! 
Reference source not found. using the material constants. The contours are plotted at 




Chapter 3: Results and Discussion 
3.1 Mechanical properties 
 The control group exhibited fairly anisotropic properties while the ang-I and ang-II 
treatment groups exhibited more isotropic properties, as seen in Figure 6. In the graphs 
below, anisotropy can be roughly determined by examining the separation between the 
radial and the circumferential plots. Greater separation between the two sets is 
indicative of a different mechanical response along each axis.  
 
 
Six to eight samples were tested for each treatment group; some samples were 
excluded from analysis, see Table 2 for the number of samples tested and excluded. 
The reasons for excluding samples are such:  
 Sample became untethered during testing 
 The wire attachments were not placed correctly which caused the sample 
to undergo uneven loading 
Figure 6. 2nd P-K Stress vs. Green Strain from preliminary results of 




 Sample was thought to be mounted backwards (radial in the x direction 
and circumferential in the y direction) 
 Sample tore and all tension ratios could not be tested 
Table 2. Number of samples tested and number of samples excluded and included in 
analysis. 








Control 8 3 5 
Ang-I 8 3 5 
Ang-II 8 2 6 
Ang-I+Quinaprilat 7 3 4 
Ang-I+Chymostatin 6 1 5 
Ang-I+Losartan 7 2 5 
Ang-II+Losartan 8 4 4 
Ang-I+PD123,319 7 2 5 
Ang-II+PD123,319 8 3 5 
 
The mechanical properties of the aortic valve leaflets can be quantified from the 
1:1 ratio stress-strain data. The properties analyzed in this study were the max areal 
strain (ASmax) and anisotropic index (AI); both of these properties can be calculated 
from the Green Strain. Table 3 displays the average ASmax and AI values for each 
treatment group.  
Table 3: Average values (ave) and standard error (SEM) for ASmax and AI for 
each treatment group. 
Treatment  ASmax AI 
Control Ave 0.097 0.525 
SEM 0.014 0.084 
    
Ang-I Ave 0.115 0.581 
SEM 0.017 0.084 
    
Ang-II Ave 0.083 0.463 
SEM 0.018 0.083 
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Ang-I+ 
Quinaprilat 
Ave 0.098 0.513 
SEM 0.011 0.119 
    
Ang-I+ 
Chymostatin 
Ave 0.083 0.507 
SEM 0.013 0.084 
    
Ang-I+ 
Losartan 
Ave 0.110 0.385 
SEM 0.025 0.055 
    
Ang-II+ 
Losartan 
Ave 0.076 0.321 
SEM 0.011 0.054 
    
Ang-I+ 
PD123,319 
Ave 0.094 0.361 
SEM 0.012 0.062 
    
Ang-II+ 
PD123,319 
Ave 0.094 0.455 
SEM 0.012 0.072 
 
The ang-I treatment group had a higher ASmax than the control group while the 
ang-II group had a lower ASmax than the control. When ang-I was combined with an 
ACE inhibitor, it had a similar ASmax to the control and a lower ASmax than the ang-I 
treatment group (Figure 7a). When supplemented with an AT-1R antagonist, the groups 
kept the same trend of ASmax with the ang-I group having a higher ASmax than the 
control and the ang-II group having a lower ASmax than the control (Figure 7b).  
The ang-I group had a higher AI than the control while the ang-II group had a 
lower AI than the control. Ang-I supplemented with an ACE and chymase inhibitor had 
similar values which were slightly lower than the control (Figure 7c). When the ang-I 
and ang-II groups were supplemented with an AT-1R inhibitor both group had an AI 
which was lower than the AI for the control, ang-I, and ang-II groups. When ang-I and 
ang-II were supplemented with an AT-2R inhibitor both groups had AI values lower than 
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the control and ang-I values. The ang-II and ang-II supplemented with AT-2R groups 
had similar AI values (Figure 7d).  
 
Figure 7. The areal strain for (A) enzyme and (B) receptor inhibitors and the strain 
anisotropy for (C) enzyme and (D) receptor inhibitors. Red dotted line is the untreated, 
native leaflets. 
The anisotropic index is a measure of how even the mechanical response is 
along each axis; a value of 1 indicates a completely isotropic, or even, response of the 
tissue. All treatment groups had an AI value lower 0.6. The treatment groups with the 
lowest calculated AI were the ang-I and ang-II supplemented with losartan, the AT-1R 
antagonist. This would imply that the anisotropic qualities of the tissue increase when 
the binding of ang-II to AT-1R is blocked. When supplemented with an AT-2R inhibitor, 
the ang-II group had a similar AI to the ang-II only group. This finding implies that the 
effects seen in the AI of the ang-II group was due to the binding of ang-II to AT-1R. 
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3.2 Choi-Vito Model 
 All five ratios of the biaxial protocol data for each treatment group were 
simultaneously fit to the Choi-Vito constitutive model shown in Eq. (6). The Choi-Vito 
model appears to not be the best choice to use for modeling the aortic valve leaflets based 
on the R2 value. The R2 values, seen in Table 4, for the individual data ranged from 0.607 
to 0.903. While the R2 values, seen in Tables 5, for the average data of each testing 
procedure ranged from 0.71 to 0.86. 
Table 4. Material constants c, c1, c2, c3 for the Choi-Vito constitutive model, R2 of fit, and 
AI for individual specimens by fitting the experimental data.  
Treatment 
Sample 
No. c(kPa) c1 c2 c3 R2 AI 
Control 1 1.114 14.332 5.162 5.162 0.626 0.360 
 2 3.491 9.441 6.779 -12.128 0.779 0.718 
 3 0.300 27.992 16.270 13.298 0.741 0.581 
 4 0.200 22.948 17.743 16.848 0.903 0.773 
 5 0.200 22.948 17.743 16.848 0.903 0.773 
 6 0.856 36.681 8.295 8.295 0.750 0.226 
 7 1.100 33.189 12.341 12.341 0.820 0.372 
 8 1.234 43.863 8.213 8.213 0.785 0.187 
 Ave 1.062 26.424 11.568 8.610 0.788 0.499 
 SEM 0.134 1.430 0.642 1.171 0.011 0.030 
        
Ang-I 1 0.603 16.220 7.301 7.301 0.721 0.450 
 2 2.366 18.333 5.292 -12.509 0.747 0.289 
 3 0.593 31.149 3.895 3.895 0.696 0.125 
 4 2.404 14.561 8.231 -13.690 0.790 0.565 
 5 1.581 29.922 24.998 -36.784 0.668 0.835 
 6 1.423 27.337 7.000 7.000 0.757 0.256 
 7 2.373 13.715 7.309 -14.601 0.717 0.533 
 8 1.758 36.954 14.514 -27.064 0.816 0.393 
 Ave 1.638 23.524 9.817 -10.806 0.739 0.431 
 SEM 0.093 1.109 0.860 2.019 0.006 0.027 
        
Ang-II 1 1.121 29.178 4.726 4.726 0.768 0.162 
 2 1.183 20.515 11.528 -23.456 0.679 0.562 
 3 1.468 14.327 10.574 -23.524 0.696 0.738 
 4 4.467 12.950 2.223 2.223 0.706 0.172 
22 
 
 5 0.370 30.374 11.194 10.646 0.818 0.369 
 6 1.430 44.319 8.174 8.174 0.710 0.184 
 7 0.747 30.220 14.335 14.335 0.634 0.474 
 Ave 1.541 25.983 8.965 -0.982 0.716 0.380 
 SEM 0.192 1.564 0.603 2.266 0.009 0.032 
        
  c(kPa) c1 c2 c3 R2 AI 
Ang-I+Losartan 1 0.747 30.220 14.335 14.335 0.634 0.474 
 2 1.406 14.346 3.063 3.063 0.679 0.214 
 3 2.039 25.608 3.106 3.106 0.640 0.121 
 4 0.341 65.057 8.275 -28.136 0.799 0.127 
 5 1.004 22.043 8.810 -15.462 0.761 0.400 
 6 0.713 72.990 11.843 11.843 0.675 0.162 
 Ave 1.042 38.377 8.239 -1.875 0.698 0.250 
 SEM 0.100 4.071 0.759 2.763 0.011 0.025 
        
  
Ang-II+Losartan 1 0.739 31.089 7.305 7.305 0.662 0.235 
 2 0.439 33.220 14.113 14.113 0.711 0.425 
 3 0.173 98.673 8.343 8.343 0.679 0.085 
 4 1.856 24.858 17.036 -31.148 0.702 0.685 
 5 1.269 29.102 5.783 5.783 0.662 0.199 
 6 0.986 40.985 8.444 8.444 0.759 0.206 
 7 0.564 59.538 26.160 -37.708 0.763 0.439 
 8 0.865 80.660 10.242 10.242 0.655 0.127 
 Ave 0.861 49.766 12.178 -1.828 0.699 0.300 
 SEM 0.066 3.403 0.845 2.543 0.005 0.025 
        
Ang-I + 
PD123,319 1 0.410 28.926 9.861 9.861 0.772 0.341 
 2 2.260 21.812 2.921 2.921 0.662 0.134 
 3 2.317 30.176 8.505 -18.214 0.767 0.282 
 4 3.263 37.142 8.532 -26.667 0.749 0.230 
 5 1.526 33.770 6.690 6.690 0.672 0.198 
 Ave 1.955 30.365 7.302 -5.082 0.724 0.237 
 SEM 0.212 1.152 0.539 3.262 0.011 0.016 
        
Ang-II + 
PD123,319 1 1.417 20.793 8.798 -28.643 0.618 0.423 
 2 2.217 21.015 2.494 2.494 0.644 0.119 
 3 1.244 33.999 6.071 -18.889 0.708 0.179 
 4 0.625 73.364 7.354 7.354 0.736 0.100 
 5 0.645 26.919 11.994 11.994 0.762 0.446 
 6 0.291 17.494 10.886 10.620 0.854 0.622 
 Ave 1.073 32.264 7.933 -2.512 0.720 0.315 
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 SEM 0.117 3.494 0.574 2.844 0.014 0.035 
        
Ang-I + 
Quinaprilant 1 2.219 18.480 11.652 -23.695 0.752 0.631 
 2 1.481 25.704 6.113 -16.414 0.813 0.238 
 3 3.583 8.497 2.574 -6.407 0.677 0.303 
 4 0.935 57.275 7.183 -28.019 0.740 0.125 
 5 2.033 22.670 6.121 -14.424 0.663 0.270 
 6 0.283 28.638 23.409 21.304 0.879 0.817 
 7 0.648 47.512 12.011 12.011 0.752 0.253 
 Ave 1.598 29.825 9.866 -7.949 0.754 0.377 
 SEM 0.161 2.418 0.975 2.622 0.011 0.036 
        
Ang-I + 
Chymostatin 1 0.995 38.906 7.482 7.482 0.818 0.192 
 2 0.508 25.891 10.024 -14.077 0.755 0.387 
 3 1.855 28.464 6.488 -22.496 0.607 0.228 
 4 0.962 34.604 5.625 -12.862 0.706 0.163 
 5 1.388 52.711 11.805 -51.943 0.616 0.224 
 6 0.403 29.508 16.615 16.615 0.824 0.563 
 Ave 1.019 35.014 9.673 -12.880 0.721 0.293 
 SEM 0.091 1.641 0.684 4.017 0.016 0.026 
 
Table 5. Average Choi-Vito model data with material constants, the R2 value, and the 
Anisotropic Index. 
Treatment c(kPa) c1 c2 c3 R2 AI 
Control 2.472 18.909 7.446 -19.715 0.732 0.394 
Ang-I 3.559 17.276 6.017 -13.599 0.781 0.348 
Ang-II 2.330 30.750 8.754 -30.804 0.725 0.285 
Ang-I + Losartan 1.396 28.093 4.975 4.975 0.773 0.177 
Ang-II + Losartan 2.225 33.730 7.370 -22.803 0.710 0.219 
Ang-I + 
PD123,319 1.251 38.825 8.036 8.036 0.802 0.207 
Ang-II + 
PD123,319 1.998 30.643 6.702 -20.750 0.768 0.219 
Ang-I + 
Quinaprilant 0.524 27.469 10.690 10.690 0.868 0.389 
Ang-I + 





Utilizing the mathematical model, material constants can be utilized to 
approximately describe the tissue response; the material constants can be seen in Table 
4. A negative value for a material constant indicates that the corresponding term in the 
Choi-Vito model, Eq. (6), had a negative contribution to the overall strain energy.  
It should be noted that there are two methods to obtain average material constants. 
The first method is to obtain material constants for individual tests and then average the 
material constants while the second method is to average the data before obtaining the 
material constants. The data reported in Table 4 was calculated through the second 
method.  
The anisotropic index of this data does not support the original hypothesis that 
treating the tissue samples with angiotensin-II would produce disease-like mechanics. 
The data implies the opposite; when ang-II is added, instead of increasing the isotropy, 
the anisotropy is increased.   
The data with the Choi-Vito model applied to them was also graphed. Figure 8 
shows plots of the average data for each of the treatment groups with the Choi-Vito model 























Figure 8: The Choi-Vito constitutive fit along the experimental data in the 














































































There is a method of determining if the model used is robust enough and 
accurate for the data analyzed. The material constants obtained from the model were 
used to plot a constant strain energy contour over the strain field. This was done to 
verify the convexity of the strain energy function over a range of strains [21]. All plots, 
seen in Figure 9, are convex in nature; this indicates that the model is reliable. 
However, the contour plots for a more reliable model would be perfectly convex and 
show a series of concentric rings as opposed to the non-circular shapes produced from 
the Choi-Vito constants.  
    
   
   
Figure 9. Constant strain energy contours plotted over the Green strain field for the 




Chapter 4: Conclusion and Future Work 
 The objective of this study was to investigate how the mediators of RAS affected 
the mechanical function of the valve leaflets. This was done by treating aortic valve 
leaflets with ang-I, ang-II, ang-I + quinaprilat (ACE inhibitor), ang-I + chymostatin 
(chymase inhibitor), ang-I + losartan (AT-1R inhibitor), ang-II + losartan, ang-I + PD123-
319 (AT-2R inhibitor), ang-II + PD123-319, or a vehicle (DMEM).  
 In the first part of the study, the samples were exposed to biaxial mechanical 
testing after being treated. The five different tension ratios tested were as follows: Tcirc:Trad 
– 1:1, 1:0.75, 1:0.5, 0.75:1, 0.5:1, with a maximum tension of 90 N/m. Key findings from 
this study are as follows:  
 Samples treated with receptor inhibitors possessed the lowest AI which 
implies that these samples became more anisotropic.  
 The effect which ang-II had on the tissue’s mechanics came from ang-II 
binding with AT-1R. 
 Mechanical properties produced in the enzyme inhibitor groups were similar 
to the control. This implies that when ang-I is unable to be converted into 
ang-II the native properties are maintained.  
There were two main limiting factors in this part of the study: tissue treatment time 
and the biaxial testing system used. The treatment time had to be limited to 48 hours as 
samples were prone to become contaminated if treated for longer periods of time. The 
effects of ang-II could be seen when limiting it to bind to just one receptor, however, the 
time given for ang-II to bind to either receptor when given the option to bind to both AT-
1R and AT-2R was not enough. The mechanical testing in the current biaxial tensile 
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testing system was also a limiting factor. The current load cells are rated for 400 N and 
thus are not sensitive at the lower tension values. Additionally, the system is displacement 
based. This means that the desired tension ratio could not be entered but rather the 
sample was subjected to multiple tests to determine the correct displacement for a 
desired tension ratio. Furthermore, tensions could vary as much as ± 7N/m on certain 
samples.  
In the second part of the study, a constitutive model, the Choi-Vito model, was 
utilized to characterize the biomechanical changes which occur due to RAS mediators 
acting on the aortic valve. The Choi-Vito model appeared to be a good model to use to 
characterize the leaflets mechanical properties since it is widely used for soft, anisotropic 
tissues. Material constants were derived for individual samples and averaged, and 
material constants were also derived from averaged biaxial data. Key findings from this 
part of this part of the study are listed below:  
 The Choi-Vito model produced non-linear curves which was seen in the 
data. 
 The R2 value was relatively low ranging from 0.71 to 0.86 for the average 
response for each treatment.   
Future work would involve multiple improvements. The first improvement would be 
obtaining load cells which would be suitable to the tissue. These would allow for more 
precise data acquisition at lower tension values which would in turn increase the accuracy 
of the material constants generated by the model. Additionally, other models, such as the 
Fung or Mooney-Rivlin models, could be utilized. The next direction for future work to take 
would be to perform immunohistochemistry on the tissue to further investigate the 
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biological changes the tissue undergoes. Lastly, quantitative polarized light imaging could 
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Appendix A: Protocols 
A1: Preparing for Slaughterhouse trip to Collect Large Animal Samples 
Reagents and Materials: 
Reagent Notes 
10x PBS VWR #101076-194 
70% EtOH In spray-bottle 
Penicillin-Streptomycin (10,000 U/mL)  ThermoFisher #15140122 
(15 mL aliquots; -20°C freezer) 
Distilled water 40 mL in 50 mL conical  
  
Materials Notes 
30 mL syringe Sterile 
Filter  
6L container  
Aluminum foil  
Surgical tools  Large scissors, small scissors, scalpel 
handle, larger straight and smaller 
curved tweezers 
Stainless steel tray  
Absorbent pads (2)  
250 ml beaker  
 
Protocol: 
Calling slaughterhouses and schedules 
MSML works with two slaughterhouses. As of November 2018, the following is the 
contact information and schedules for them: 
 
 Cockrum’s Meat Processing (Rudy, AR) 
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o Phone number: (479) 474-3012 
o Receive pigs on Sundays and Thursdays. Slaughter on Mondays and 
Fridays. 
o Open Mon-Fri 8am-5pm; Saturday 8am-noon; Sunday 2pm-5pm 
o Call two days before as sometimes they slaughter a day early if they have 
to many 
 Braunschweig Processing (Neosho, MO) 
o Phone number: (417) 451-3150 
o Receive pigs on Sundays, Tuesdays, and Wednesdays. Slaughter on 
Mondays, Wednesdays, and Thursdays. 
o Open Mon-Fri 8am-5pm; Saturday 9am-12pm 
 
Always call day before close to closing time to see how many pigs they will have. Call 
the morning of to remind them to save the hearts and make sure what time the hearts 
will be ready. Time will vary as they slaughter beef prior to pork and time depends on 
how many beef they have.  
Preparing diluted pen/strep (can be days before dissecting)  
1. Thaw pen/strep in water bath 
2. In hood, mix 1 mL pen-strep with 40 mL ddH2O 
3. Sterilize with 30 mL syringe and filter 
4. Aliquot in ~12 mL of reagent into three 15 mL conicals 
5. Place in -20°C freezer 
Preparing PBS (day before dissecting) 
1. Prepare required amount of 1x PBS from 10x PBS stock. (Call slaughterhouse day 
before to know how many hearts will be available) 
a. 300 ml 10x PBS + 2700 ml ddH2O if picking up less than 3 hearts 
b. 200 ml 10x PBS + 1800 ml ddH2O if picking up more than 4 hearts. Max that 
can fill is 8 
2. Fill appropriate sized polycarbonate containers with 1x PBS.  
3. Cover top of container with aluminum foil. 
4. Autoclave in liquid setting. Do not remove foil at any point when container is outside 
5. Return autoclaved containers to biosafety hood in lab using sterile technique.  
a. Container is very hot after autoclaving. Either wait for it to cool down or use 
gloves to carry. 
b. Sterile technique: spray container with 70% alcohol before placing in hood 
6. Remove foil, switch on UV light and expose overnight. 
 
Preparing tools (day before dissecting) 
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1. Autoclave the following surgical tools in wrapped setting 
a. Small pack: Large scissors, small scissors, scalpel handle, larger straight and 
smaller curved tweezers 
b. Large pack: Stainless steel tray and absorbent pads (2 sheets) 
c. 250 ml beaker with top covered in aluminum foil 
2. Place in lab bench until use 
 
A2: Biaxial stretching of soft tissues 
Important things to remember: 
 If using tissue samples, make sure it doesn’t dry out by constantly adding a few 
drops of deionized water. 
 When you turn on the actuators sometimes one of the axis might make a noise 
trying to pull itself inside. Make sure to switch off the controller on the software and 
follow these steps for trouble shooting; 
o In the cycle menu, change the settings to regular mode. 
o Check all the actuators are being operated in position mode and not in load 
mode. 
o Bring all the actuators closer and change the settings back to biaxial mode in 
the cycle menu. 
 
 




0.9% Saline Dissolve 54 grams of NaCl in 6 L of DI 
water 
PDMS  For mold to fix sample 
 
Materials Notes 
Water Sprayer Keep sample moist at all times 
Small and large petri dish For PDMS mold and to cut samples 
1cm x 1cm metal stamp Used as stencil to cut sample 
Cardboard frame Sample is fixed to cardboard frame and is 
gripped onto grips 
Staples To fix sample to cardboard frame 
Super glue To administer tracking nodes 
Black beads To administer tracking nodes 
Scissors To cut cardboard frame 
Razor blade and forceps To excise sample and mount on frame 
Water pump To empty and fill water bath 
 
Protocol:  
Preparing material prior to day of testing 
Prior to testing on day of 
1. Place 6L of saline solution into water bath and turn on heating unit. Wait for at 
least 1 hour for solution to reach 37ºC. 
 
Setting up system 
1. Turn on all the actuators using the power knob under the desk. 
2. On the left screen, start the application named “MTL32” and once it loads, open 
“Testbuilder.” 
3. In Testbuilder application, click on Proceed. 
4. On the tab choose Test > Function generator. 
5. On the right screen, open the tracking software named “Video Gauge.” 
6. Transfer the 6 L of prepared saline into the bath and turn on the heater  
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7. Mount the sample onto the cardboard frame and clamp them using grips. 
8. Mark four points forming a square on the tissue sample using small black beads 
and a miniscule amount of glue. 
9. Mount the cardboard frame with the loaded sample onto one of the actuators and 
clamp it.  
10. Now move the actuators one by one using the Jog function on the testbuilder 
screen and mount the other sides of the cardboard frame to the other actuators.  
11. Cut the cardboard pieces in such a way that each actuator is gripping onto one 
side of the sample. 
12. Use the DAQ settings to create a new file for each test and set the frame rate at 
100 Hz on both the computers that control the stretcher and video gauge 
software. You can navigate to the settings by clicking on Option> GigE camera> 
Sensors > 100Hz/ 100000 acquisition frames. 
13. Using the jog function bring all the actuators closer so that the sample is not 
expressing any load from any side. 
14. Offset all the loads of the actuators. Setup > Offset readout. 
15. Move each of the actuators until they all reach a tear load of 0.05N. 
16. Offset all the positions of the actuators. Setup > Offset readout 
17. Choose the Cycle function and set the number of stretches desired. The Biaxial 
tab is where you can control if you want your actuators to work individually or 
biaxially. Make sure to set it up at biaxial before running the test. 
 
18. Set waveform to “Ramp” with a mean strain of 0.75 and amp of 0.75. Ensure you 
select the “start point min” option to ensure the test begins at the relaxed state 





19. Run 20 cycles of preconditioning. Wait for 5 minutes. 
20. On the right screen, click on “Start test” to let the video start recording.
 
 
21. Click on Start from the left screen. Run and record three cycles of stretch.  
22. Once the test is done, click on “Report” and in the following screen choose single 
and click on “Single File”. This brings up another dialog box where you choose 
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the file name that was created in the DAQ settings. 
 
23. In the following screen, choose the file type as “CSV”; select all the loads for 
each actuator and export it. Save this CSV file to your desired location. 
 
24. The saved file is ready to be analyzed using MATLAB. 
25. Optional: For a quick view at the results, in the above shown screen you can 
choose “Preview” to look at the graphs.  
 





Video File .avi extension 
Strain data .csv file 
Windows Photos To edit video 
Matlab To analyze data 
 
Protocol: 
1. Import the video file of the biaxial test. 
2. Scrub through the video to determine which range of frames are of interest 
(Windows default photo viewer can be used). 
3. Extract only the range of frames of interest by deleting all frames which aren’t of 
interest. Each stretch should be saved individually. 100 frames corresponds to 
one stretch.  
4. Navigate to the ‘BiaxialImagesandData’ by going to ResearchProjects, MATLAB 
codes. 
5. Open the ‘Biaxial_1’, ‘Biaxial_2’, ‘Biaxial_3’ and ‘automarkertrack’ codes.  
6. Navigate to the folder in which your images and .csv files are saved. Move that 
folder into the MATLAB folder. When running ‘Biaxial_1’ a specific test will have 
to be chosen. 
7. Run ‘Biaxial_1’. The output will be tensions in the y- and x-axes. The stretch 
closest to the desired ratio should be chosen.  
8. In the folder which contains the images, mark which stretch will be used by 
adding a ‘+’ to the name of the stretch. (i.e. Stretch 1+)  
9. In ‘Biaxial_2’ lines 27, 28, and 29 will need to be altered before running the code.  
a. In line 27, ‘path1=’ will need to be changed to the path name 
for the stretch of interest. (i.e. 
'E:\Biaxial\2018_12_17_vertical\AngII+PD_FB7\test 13_0.75_1\stretch 
3+';).  
b. In line 28, ‘name1=’ will need to be changed to the name of 
the first image. Note that three additional numbers will appear after the ‘0’, 
highlight those numbers and press Ctrl+x. They will be needed when the 




c. In line 29, ‘out1=’ will need to be changed to the output path. 
(i.e. 'E:\Biaxial\MATLAB\BiaxialImagesandData\point'; 
10. When pasting the location of the output folder, ensure that behind the location 
you add ‘\point’ in order to name some of the exported ‘.txt’ files correctly.  
11. Open ‘automarkertrack.m’, lines 5 and 6 will need to be altered. Line 5 will need 
to read ‘pixel=50;’ and line 6 will need to read ‘num=10;’.  
12. Press Run on the ‘Biaxial_2’ code.  
13. You will be prompted to enter the number of the first image; this is the number 
which was cut from the file name when altering line 28.  
14. If the code runs without error then a window in MATLAB will appear with the first 
of the 100 images. Each dot will need to be clicked on once starting at the bottom 
right and proceeding clockwise.  
15. The code should run all the way through and display graphs of Exx and Eyy to 
preview. These seven files will also be exported into the indicated output folder: 
‘point1.txt’,’point2.txt’,’point3.txt’,’point4.txt’, ‘deformresults.xlsx’, ‘defg.mat’, and 
‘lamz.mat’.  
16. Run ‘Biaxial_3’  
17. You will be prompted to select a file. Select the .csv file for the ratio being 
analyzed.  
18. Two prompts will then appear on the screen. The first asks how many stretches 
were done and the second asks which stretch will be analyzed. Answers to these 
prompts are obtained after running ‘Biaxial_1’.  
19. Run ‘Biaxial_4’ 
20. You will be prompted to enter the thickness of the sample in millimeters. The 
output of ‘Biaxial_4’ is E11, E22, S11, S22, P11, P22, and Areal Strain. These 




Appendix B: Choi-Vito Model Data 































C2: Strain Energy Density 
 
